EUFEPS Strategic Plan 2013-2017

 

EUFEPS

 

Strategic Plan

 

2013 – 2017

 

Adopted at
Council Business Meeting,
June 26, 2013

 


 

 

 

1     Executive summary

2     Mission

3     Membership – development and communication

4     Federation administration, management and finance

5     Meetings and events development –management and communication

6     Science development and policy, research, education and training

7     European affairs

8     Global affairs

 

1         Executive summary

In 2011 the EUFEPS strategic plan 2011 – 2015 has been adopted. In the meantime there have been major changes in the field of medicines & health research and within EUFEPS. This has prompted the preparation of a new strategic plan 2013 – 2017, rather than an update of the existing plan.

 

Mission

The mission of EUFEPS has been rephrased in terms of “the advancement of sciences for better medicines and health”.

EUFEPS has the ambition to assume a leading role in the development and dissemination of a European view on medicines and health research. This concerns in particular the European Strategic Research Agenda (ESRA) and the European Strategic Research, Education and Training Agenda (ESRETA).

 

Membership development

EUFEPS aims to enlarge its membership constituency with societies from eastern European countries and societies from the near and middle east. In addition it also aims to increase the numbers of member societies in the current countries, the institutional members and the individual members.

Another important aim and task is to intensify the communication with the various membership categories, in meetings, conferences, the website and the social media. Initially this means with existing and new member societies, through the debate on important science policy issues. The next will be the communication with member institutions and discussions on the European “strategic research, education & training agenda” also aiming at the development and consolidation of collaboration. Finally, it will upgrade the communication with individual members through the development and creation of networks.

A new initiative is the creation of “Young Pharmaceutical Scientists” group, as a platform of and for PhD students and Postdocs within EUFEPS.

 

Federation administration, management and finance

To achieve its goals, it is crucial to strengthen the staffing of the EUFEPS headquarters to consist of: a Chief Executive Officer (0.5 fte), a Chief Scientific Officer (0.5fte) and a Chief Education and Training Officer (0.5 fte) supported by administrative staff.

A major concern is the financial position of EUFEPS. To strengthen the financial position it proposed to establish a taskforce on the long term financial sustainability of EUFEPS under the leadership of the Treasurer of the Executive Committee.

 

Meetings and events – development, management and communication

The organization of meetings and events is crucial to mission of EUFEPS.

EUFEPS takes the initiative to organize an Annual Meeting. The annual meeting serves as a platform for i) science policy: round tables, debates, ii) research: symposia, network meetings, iii) education & training: short courses and iv) business meetings. A special feature will be the organization of a networking event for SME ‘s and big pharma.

EUFEPS assumes, as an exclusive partner of the main organizer FIP, responsibility for the development of the scientific programme of the Pharmaceutical Sciences World Conference 2017 in Europe

EUFEPS will continue the organization of a number of important and high profile meetings in the field of medicines research, development, processing and usage including: • the series of BBBBB conferences, • the World Conference on Drug Absorption, Transport and Delivery (WCDADT), • the meetings of the Global Bioequivalence Harmonization Initiative (GBHI) and • EuPAT.

 

Science development and policy – research, education and training

The EUFEPS Council on the initiative of the Executive Committee, supported by the EUFEPS Senate assumes the responsibility for the development and dissemination of a European vision on medicines and health research, including education and training.

EUFEPS will engage in promoting/leading/coordinating a “European infrastructure in medicines research” through the establishment of a broad platform of solid competences, and in education and training.

EUFEPS assumes the role of representing body of scientists in medicines and health research. The dissemination of scenario analysis outcomes will include the general public, politicians etc.

 

European affairs

EUFEPS acts a representative the body of scientists in medicines science and health research at the European Level. To this end, EUFEPS will initiate and intensify contacts with • policy makers within the European Union (European MP’s and directorates of the EC), •(regional) learned societies and federations (e.g. Ephar; EACPT; in the European Pharma Sciences Leadership Forum, EuPSLF) and • public institutes/institutions with an interest and role in engaging in future IMI and/or Horizon 2020 calls.

 

Global affairs

EUFEPS assumes an active role in the International Pharmaceutical Federation (FIP), particularly in its Board of Pharmaceutical Sciences (BPS)

EUFEPS aims to intensify collaboration with relevant global associations such as the World Health Organization (WHO) in advancing sciences for better medicines and health.

EUFEPS pursues bilateral collaboration, cooperation and coordination with other regional organisations/representative bodies including AAPS, JSSX; DUPHAT, APSA, APSTJ.

 

2         Mission

The mission of the European Federation for Pharmaceutical Sciences (EUFEPS) is the advancement of sciences for better medicines and health in Europe. This includes: • drug discovery & development, • drug regulation, • drug usage, • education & training and • drug policy making. (Figure 1)

As a federation of 23 national societies, EUFEPS is the representing body of 18.000 scientists in medicines and health research in Europe. EUFEPS achieves its goals through: • the development of a European view on medicines and health research, • the organization of meetings and workshops, • the establishment of research networks, • the coordination of education and training, • the representation of scientists in medicines and health research and • the liaison with pertinent international organizations.

 

Figure 1. Sciences for better medicines and health includes: 1) fundamental research on the discovery and development of novel drug and targets, 2) translational research for the transition of the research findings from the laboratory to the patient and vice versa, 3) research on the manufacturing, production and quality control of new drugs and devices and 4) the usage of new drug treatment solutions in practice.

 

3         Membership – development and communication

EUFEPS is a federation of 23 societies in medicines and health research in Europe, representing a total of 18.000 scientists. Within EUFEPS three membership categories can be distinguished, each with a unique role. 

  1. Member Societies (23 societies in 23 European countries
  2. Member Institutions (10 institutions in 10 European countries )
  3. Individual Members (approximately 250)

The roles of the various membership categories are summarized in table 1. 

Membership Issues EUFEPS main role
Member Societies
  • Science policy
  • Representation at European Union
  • Research
  • Education & Training
  • Forum for policy development
  • Representative body
  • Leader of (the discussion on) a European research agenda
  • Leader of (the discussion on) a European education & training agenda
Institutional members
  • Education & training
  • Research
  • Leader of (the discussion on) a European education & training agenda
  • Leader of (the discussion on) a European research agenda
Individual members
  • Research
  • Education & training
  • Leader of a European research agenda
  • Leader of a European education & training agenda

EUFEPS aims to enlarge its membership constituency with societies from eastern European countries and societies from the near and middle east. In addition it also aims to increase the numbers of member societies in the current countries, the institutional members and the individual members.

Another important aim and task is to intensify the communication with the various membership categories, in meetings, conferences, the website and the social media. Initially this means with existing and new member societies, through the debate on important science policy issues. The next will be the communication with member institutions in discussions on the European “strategic research, education & training agenda” also aiming at the development and consolidation of collaboration. Finally, it will upgrade the communication with individual members through the development and creation of networks.

A new initiative is the creation of “Young Pharmaceutical Scientists” group, as a platform of and for PhD students and Postdocs within EUFEPS.

 

4 Federation adminsitraion, managemet and finance

Formally the President is also the Chief Executive Officer (CEO) of EUFEPS. In the past the President was supported by the Executive Director (ED), who in turn was supported by administrative staff. At present EUFEPS employs an Office & Promotion Manager. In addition the former Executive Director is still very active especially in the fields of science policy and education & training.

To achieve its goals, it is crucial to strengthen the directorate of EUFEPS to consist of: a Chief Executive Officer (0.5 fte), a Chief Scientific Officer (0.5fte) and a Chief Education and Training Officer (0.5 fte) supported by administrative staff.

A matter of great concern is the financial position. Briefly, EUFEPS has the following sources of income: i) membership fees (Societies, Individual Members, and Member Institutions), ii) royalties from EJPS, iii) profit on meetings, workshops etc., iv) financial support. The income from these sources is by and large insufficient to cover the expenses of the operation of EUFEPS. Immediate action is required to overcome this problem. To strengthen the financial position it proposed to establish a taskforce on the long term financial sustainability of EUFEPS under the leadership of the Treasurer of the Executive Committee.

 

5         Meetings and events development –management and communication

To achieve the goals of EUFEPS the organization of meetings is crucial. To accommodate this EUFEPS has established “Pharm Sci Events Europe” as an independent professional entity for the organization for the conferences, symposia and workshops

EUFEPS takes the initiative to organize an Annual Meeting.

  • The annual meeting serves as a platform for i) science policy: round tables, debates, ii) research: symposia, network meetings, iii) education & training: short courses and iv) business meetings. A special feature will be the organization of a networking event for SME ‘s and big pharma.
  • It is foreseen that a number of otherwise independently organized activities within EUFEPS, can be held at the annual meeting (table 1). This includes: meetings of the research networks and various business meetings. In this manner the annual meeting contributes to the efficiency of the participation in EUFEPS activities. Moreover it offers an opportunity for networking and cross fertilization. Finally is contributes to the ‘visibility’ of EUFEPS, its members and its activities.
Table 2Annual Meeting activities
Topic Activities
Science policy
  • Debates
  • Round tables
  • Open and closed workshops
Research
  • Plenary lectures
  • Symposia/workshop/conference/congress
  • Network meetings
Education & training
  • Short courses
  • Other
Business meetings
  • EUFEPS Council
  • Executive Committee
    = ExCo Network Coordination Board
    = ExCo Science Policy group
  • Network Steering Committee
  • Committee on Industrial Research Relations
  • Committee on Education & Training
  • Committee on Membership Development
  • Senate

 

EUFEPS assumes, as an exclusive partner of the main organizer FIP, responsibility for the development of the scientific programme of the Pharmaceutical Sciences World Conference 2017.

EUFEPS will continue the organization of a number of important and high profile meetings in the field of medicines research including: • the series of BBBBB conferences, • the World Conference on Drug Absorption, Transport and Delivery (WCATD)and • the meetings of the Global Bioequivalence Harmonization Initiative (GBHI) and • EuPAT.

 

6         Science development and policy, research, education and training

EUFEPS has the ambition to provide a forum for policy development in the pharmaceutical sciences, particularly in relations to the discovery and development of new drugs and their introduction into the market, but also as to medicines usage. This includes policies on and leadership development as to: research, education & training, profiling and regulatory affairs.

The EUFEPS Council on the initiative of the Executive Committee, supported by the EUFEPS Senate assumes the responsibility for the development and dissemination of a European vision on medicines and health research, including education and training.

EUFEPS will engage in promoting/leading/coordinating a “European infrastructure in medicines research” through the establishment of a broad platform of solid competences, and in education and training.

The EUFEPS Executive Committee and Council, supported by the EUFEPS Senate will assume the responsibility for the development and dissemination of a European vision on medicines and health research, including education and training. EUFEPS is prepared to assume the role of representing body of scientists in medicines and health research. The dissemination of the European vision will include the general public, politicians etc.

7         European affairs

EUFEPS acts a representing body of scientists in medicines and health research at the European Level. To this end, EUFEPS will intensify contacts with • policy makers within the European Union (European MP’s and directorates of the EC), • (regional) learned societies and federations (EPHAR; EACP, European Pharmaceutical Sciences Leadership Forum, EuPSLF) and • public institutes/institutions with an interest in engaging in future IMI and/or Horizon 2020 calls.

 

8         Global affairs

EUFEPS assumes an active role in the International Pharmaceutical Federation (FIP), particularly in its Board of Pharmaceutical Sciences (BPS)

EUFEPS aims to intensify collaboration with relevant global associations such the World Health Organization (WHO)

EUFEPS pursues bilateral collaboration, cooperation and coordination with other regional organisations/representative bodies including AAPS, JSSX; DUPHAT, APSA, APSTJ.